1 |
SCHOTTEN U, VERHEULE S, KIRCHHOF P, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal[J]. Physiol Rev, 2011, 91(1): 265-325.
|
2 |
SCHMIDT B, BORDIGNON S, CHEN S J, et al. What does the future hold?: ideal device, newer devices, and more[J]. Card Electrophysiol Clin, 2020, 12(1): 125-130.
|
3 |
SO C Y, LAM Y Y, CHEUNG G S H, et al. Occlusion of a multilobed shallow left atrial appendage using a special LAmbre device after failed Watchman implantation[J]. J Invasive Cardiol, 2019, 31(2): E41-E42.
|
4 |
中国医师协会心血管内科医师分会结构性心脏病专业委员会. 中国经导管左心耳封堵术临床路径专家共识[J]. 中国介入心脏病学杂志, 2019, 27(12): 661-672.
|
5 |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会. 心房颤动: 目前的认识和治疗的建议(2018)[J]. 中华心律失常学杂志, 2018, 32(4): 279-346-268.
|
6 |
ITO T, SUWA M. Left atrial spontaneous echo contrast: relationship with clinical and echocardiographic parameters[J]. Echo Res Pract, 2019, 6(2): R65-R73.
|
7 |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国左心耳封堵预防心房颤动卒中专家共识(2019)[J]. 中华心血管病杂志, 2019, 47(12): 937-955.
|
8 |
LEON M B, PIAZZA N, NIKOLSKY E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium[J]. J Am Coll Cardiol, 2011, 57(3): 253-269.
|
9 |
MEHRAN R, RAO S V, BHATT D L, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium[J]. Circulation, 2011, 123(23): 2736-2747.
|
10 |
BURSI F, SANTANGELO G, FERRANTE G, et al. Prevalence of left atrial thrombus by real time three-dimensional echocardiography in patients undergoing electrical cardioversion of atrial fibrillation: a contemporary cohort study[J]. Echocardiography, 2021, 38(4): 518-524.
|
11 |
AKAMATSU K, ITO T, OZEKI M, et al. Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores[J]. Cardiovasc Ultrasound, 2020, 18(1): 31.
|
12 |
HARADA M, KOSHIKAWA M, MOTOIKE Y, et al. Left atrial appendage thrombus prior to atrial fibrillation ablation in the era of direct oral anticoagulants[J]. Circ J, 2018, 82(11): 2715-2721.
|
13 |
WATANABE T, SHINODA Y, IKEOKA K, et al. Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin[J]. Heart Vessels, 2017, 32(3): 326-332.
|
14 |
DURMAZ E, KARADAG B, IKITIMUR B, et al. Management of periprocedural anticoagulant therapy: a novel individualized approach—a transeusophageal echocardiographic study[J]. J Thromb Thrombolysis, 2020, 50(2): 408-415.
|
15 |
SEDAGHAT A, NICKENIG G, SCHRICKEL JW, et al. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device: insights from the EWOLUTION real world registry[J]. Catheter Cardiovasc Interv, 2021, 97(7): E1019-E1024.
|
16 |
WANG G J, KONG B, QIN T Y, et al. Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the LAmbre device: data from a prospective multicenter clinical study[J]. J Cardiovasc Electrophysiol, 2021, 32(2): 354-359.
|